BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 20843911)

  • 1. Flexible dosed duloxetine in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled trial.
    Arnold LM; Clauw D; Wang F; Ahl J; Gaynor PJ; Wohlreich MM
    J Rheumatol; 2010 Dec; 37(12):2578-86. PubMed ID: 20843911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement in multiple dimensions of fatigue in patients with fibromyalgia treated with duloxetine: secondary analysis of a randomized, placebo-controlled trial.
    Arnold LM; Wang F; Ahl J; Gaynor PJ; Wohlreich MM
    Arthritis Res Ther; 2011 Jun; 13(3):R86. PubMed ID: 21668963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
    Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ
    Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder.
    Brannan SK; Mallinckrodt CH; Brown EB; Wohlreich MM; Watkin JG; Schatzberg AF
    J Psychiatr Res; 2005 Jan; 39(1):43-53. PubMed ID: 15504423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of duloxetine in patients with chronic low back pain.
    Skljarevski V; Desaiah D; Liu-Seifert H; Zhang Q; Chappell AS; Detke MJ; Iyengar S; Atkinson JH; Backonja M
    Spine (Phila Pa 1976); 2010 Jun; 35(13):E578-85. PubMed ID: 20461028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of duloxetine 30 mg/d in patients with fibromyalgia: a randomized, double-blind, placebo-controlled study.
    Arnold LM; Zhang S; Pangallo BA
    Clin J Pain; 2012; 28(9):775-81. PubMed ID: 22971669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of patient-rated stiffness associated with fibromyalgia: a post-hoc analysis of 4 pooled, randomized clinical trials of duloxetine.
    Bennett R; Russell IJ; Choy E; Spaeth M; Mease P; Kajdasz D; Walker D; Wang F; Chappell A
    Clin Ther; 2012 Apr; 34(4):824-37. PubMed ID: 22421576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of duloxetine versus placebo in adolescents with juvenile fibromyalgia: results from a randomized controlled trial.
    Upadhyaya HP; Arnold LM; Alaka K; Qiao M; Williams D; Mehta R
    Pediatr Rheumatol Online J; 2019 May; 17(1):27. PubMed ID: 31138224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial.
    Clauw DJ; Mease P; Palmer RH; Gendreau RM; Wang Y
    Clin Ther; 2008 Nov; 30(11):1988-2004. PubMed ID: 19108787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duloxetine for the treatment of fibromyalgia in women: pooled results from two randomized, placebo-controlled clinical trials.
    Arnold LM; Pritchett YL; D'Souza DN; Kajdasz DK; Iyengar S; Wernicke JF
    J Womens Health (Larchmt); 2007 Oct; 16(8):1145-56. PubMed ID: 17937567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of duloxetine 60 mg once daily in the treatment of pain in patients with major depressive disorder and at least moderate pain of unknown etiology: a randomized controlled trial.
    Brecht S; Courtecuisse C; Debieuvre C; Croenlein J; Desaiah D; Raskin J; Petit C; Demyttenaere K
    J Clin Psychiatry; 2007 Nov; 68(11):1707-16. PubMed ID: 18052564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duloxetine versus placebo in patients with chronic low back pain: a 12-week, fixed-dose, randomized, double-blind trial.
    Skljarevski V; Zhang S; Desaiah D; Alaka KJ; Palacios S; Miazgowski T; Patrick K
    J Pain; 2010 Dec; 11(12):1282-90. PubMed ID: 20472510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial.
    Russell JI; Mease PJ; Smith TR; Kajdasz DK; Wohlreich MM; Detke MJ; Walker DJ; Chappell AS; Arnold LM
    Pain; 2008 Jun; 136(3):432-444. PubMed ID: 18395345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized, Double-blind, Placebo-controlled Phase III Trial of Duloxetine Monotherapy in Japanese Patients With Chronic Low Back Pain.
    Konno S; Oda N; Ochiai T; Alev L
    Spine (Phila Pa 1976); 2016 Nov; 41(22):1709-1717. PubMed ID: 27831985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients.
    Murakami M; Osada K; Mizuno H; Ochiai T; Alev L; Nishioka K
    Arthritis Res Ther; 2015 Aug; 17(1):224. PubMed ID: 26296539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of duloxetine treatment on cognition in patients with fibromyalgia.
    Mohs R; Mease P; Arnold LM; Wang F; Ahl J; Gaynor PJ; Wohlreich MM
    Psychosom Med; 2012; 74(6):628-34. PubMed ID: 22753629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duloxetine efficacy for major depressive disorder in male vs. female patients: data from 7 randomized, double-blind, placebo-controlled trials.
    Kornstein SG; Wohlreich MM; Mallinckrodt CH; Watkin JG; Stewart DE
    J Clin Psychiatry; 2006 May; 67(5):761-70. PubMed ID: 16841626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia.
    Welsch P; Üçeyler N; Klose P; Walitt B; Häuser W
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD010292. PubMed ID: 29489029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of milnacipran 100 mg/day in patients with fibromyalgia: results of a randomized, double-blind, placebo-controlled trial.
    Arnold LM; Gendreau RM; Palmer RH; Gendreau JF; Wang Y
    Arthritis Rheum; 2010 Sep; 62(9):2745-56. PubMed ID: 20496365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duloxetine for the treatment of major depressive disorder: a closer look at efficacy and safety data across the approved dose range.
    Mallinckrodt CH; Prakash A; Andorn AC; Watkin JG; Wohlreich MM
    J Psychiatr Res; 2006 Jun; 40(4):337-48. PubMed ID: 16271726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.